Table 3 Multivariate linear mixed-effect regression models assessing clinical and microbial predictors associated with gut microbiome α-diversity after liver transplantation
Predictor | Univariate coefficient | Univariate Pa | Multivariate coefficient (95% CI) | Multivariate Pa,b |
---|---|---|---|---|
Early post-LT (months 1–3) | ||||
Comorbidity—HCC | 0.30 | <0.05 | ||
MELD (>18 vs. ≤18) | −0.34 | <0.001 | −0.34 (−0.51, −0.16) | <0.001 |
CTP score | −0.07 | <0.01 | ||
Post-operative bleedingc | −0.43 | <0.01 | ||
Bile leakd | −0.73 | <0.0001 | −0.49 (−0.77, −0.22) | <0.001 |
Biliary strictured | −0.45 | <0.01 | ||
Re-hospitalizationd | −0.25 | <0.05 | ||
Readmission to ICUd | −0.37 | <0.01 | ||
Peri-operative antibiotic adjustment | −0.27 | <0.05 | −0.17 (−0.36, 0.01) | 0.07 |
CRE colonization | −0.58 | <0.01 | −0.46 (−0.78, −0.14) | <0.01 |
VRE colonization | −0.53 | <0.0001 | ||
Ceph-RE colonization | −0.23 | 0.07 | ||
β-lactam IIe | −0.84 | <0.0001 | −0.41 (−0.68, −0.14) | <0.01 |
β-lactam IIIe | −0.6 | <0.05 | ||
Glyco-/lipo-peptidee | −0.96 | <0.0001 | −0.39 (−0.7, −0.08) | <0.05 |
Carbapeneme | −0.72 | <0.001 | ||
Fluoroquinolonee | −0.73 | <0.0001 | −0.46 (−0.75, −0.17) | <0.01 |
Late post-LT (months 6–12) | ||||
Comorbidity—HCC | 0.23 | <0.05 | ||
MELD (>18 vs. ≤18) | −0.31 | <0.01 | −0.21 (−0.39, −0.03) | <0.05 |
CTP score | −0.05 | <0.05 | ||
Post-operative bleedingc | −0.29 | <0.05 | ||
Bile leakd | −0.41 | <0.05 | −0.33 (−0.64, −0.03) | <0.05 |
Biliary strictured | −0.52 | <0.001 | −0.33 (−0.58, −0.07) | <0.05 |
Re-hospitalizationd | −0.25 | <0.05 | ||
Peri-operative antibiotic adjustment | −0.19 | 0.09 | −0.18 (−0.37, −0.01) | 0.07 |
CRE colonization | −0.36 | <0.05 | ||
VRE colonization | −0.70 | <0.0001 | −0.53 (−0.78, −0.29) | <0.0001 |
Ceph-RE colonization | −0.20 | 0.05 | ||
β-lactam IIe | −0.46 | <0.001 | −0.29 (−0.54, −0.03) | <0.05 |
Glyco-/lipo-peptidee | −0.51 | <0.001 | ||
Carbapeneme | −0.55 | <0.05 |